Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Obese With Comorbidities”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Testing effectiveness (Phase 2)Looking for participantsNCT07282743
What this trial is testing

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

Who this might be right for
Type II Diabetes Mellitus
Sun Pharmaceutical Industries Limited 285
Large-scale testing (Phase 3)Looking for participantsNCT06672939
What this trial is testing

Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities

Who this might be right for
ObesityOverweight
Eli Lilly and Company 125
Not applicableStudy completedNCT04425213
What this trial is testing

Obesity and Mortality of Critically Ill Patients With COVID-19

Who this might be right for
COVIDSevere Acute Respiratory SyndromeObesity+1 more
Central Hospital, Nancy, France 250
Not applicableLooking for participantsNCT06015620
What this trial is testing

Comorbidities Resolution After MGB Surgery and Change in Body Composition

Who this might be right for
Morbid ObesityType2diabetesSleep Apnea+5 more
All India Institute of Medical Sciences, Bhubaneswar 35
Testing effectiveness (Phase 2)Study completedNCT06277934
What this trial is testing

RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
Obesity
Regor Pharmaceuticals Inc. 73
Large-scale testing (Phase 3)Looking for participantsNCT07255209
What this trial is testing

IBI362 in Chinese Adolescents With Obesity or Overweight

Who this might be right for
Adolescents With Obesity or Overweight With Weight-Related Comorbidities
Innovent Biologics (Suzhou) Co. Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT06595238
What this trial is testing

A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

Who this might be right for
Obesity or Overweight
AstraZeneca 262
Large-scale testing (Phase 3)Looking for participantsNCT07279194
What this trial is testing

Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes

Who this might be right for
Obesity & Overweight
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 825
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07497880
What this trial is testing

Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity

Who this might be right for
ObesityOverweight
Kailera 320
Large-scale testing (Phase 3)Active Not RecruitingNCT06075667
What this trial is testing

Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
ObesityOverweight
Eli Lilly and Company 150
Not applicableStudy completedNCT05623163
What this trial is testing

Evaluation of Health Improvement in Obese Patients With Obesity-related Comorbidities Followed by EndoZip Procedure

Who this might be right for
Obesity
Nitinotes Surgical Ltd. 38
Large-scale testing (Phase 3)Looking for participantsNCT07284875
What this trial is testing

Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Who this might be right for
ObesityOverweight
Kailera 1,800
Testing effectiveness (Phase 2)Active Not RecruitingNCT06965413
What this trial is testing

Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity

Who this might be right for
ObesityOverweightOverweight With One Weight Related Comorbidity
Hoffmann-La Roche 285
Early research (Phase 1)Study completedNCT06023095
What this trial is testing

LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities

Who this might be right for
OverweightObesity
Eli Lilly and Company 24
Not applicableStudy completedNCT01703546
What this trial is testing

Weight Loss & Comorbidity Resolution With LAGB Alone vs. LAGB With Gastric Plication

Who this might be right for
Morbid Obesity
Northwell Health 420
Large-scale testing (Phase 3)Looking for participantsNCT06972459
What this trial is testing

Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

Who this might be right for
ObesityOverweight
Eli Lilly and Company 600
Not applicableStudy completedNCT05072067
What this trial is testing

EFFICACY OF THE SLEEVE GASTROPLASTY WITH THE ENDOSCOPIC SYSTEM OVERSTICH SX ON WEIGHT LOSS AND REDUCTION OF CO-MORBIDITY FOR OBESE PATIENTS

Who this might be right for
Obesity
Clinique du Trocadéro 120
Early research (Phase 1)Study completedNCT04167553
What this trial is testing

Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities

Who this might be right for
Obese With ComorbiditiesOverweight With ComorbiditiesType2 Diabetes
Hanmi Pharmaceutical Company Limited 52
Large-scale testing (Phase 3)WithdrawnNCT05209984
What this trial is testing

A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight

Who this might be right for
OverweightObesity
Eurofarma Laboratorios S.A.
Large-scale testing (Phase 3)Ended earlyNCT00412698
What this trial is testing

European Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemia

Who this might be right for
ObesityDyslipidemias
Sanofi 645
Load More Results